Hospital drug and supply expenses push finance teams to rethink cost strategy
Published 7/02/26
Healthcare Financial Management Association (HFMA) explores how rising drug and medical supply costs are prompting hospitals to rethink cost management strategies. The article features insights from Dr. Emad Rizk, president and CEO of Premier, who discusses treating the supply chain as a strategic driver of financial performance and reducing unnecessary variation through integrated data, technology and clinical standardization. The piece examines how health systems can strengthen margins while improving quality and operational efficiency.
